T1	ANAT 101 137	células mononucleadas de médula ósea
T2	PROC 805 819	recanalización
#1	AnnotatorNotes T2	C0034771; Recanalization; Therapeutic or Preventive Procedure
T3	DISO 164 190	oclusión coronaria crónica
T4	PROC 203 228	revascularizada con stent
T5	ANAT 266 277	ventricular
#2	AnnotatorNotes T5	C0018827; Heart Ventricle; Body Part, Organ, or Organ Component | C1280934; Entire cardiac ventricle; Body Part, Organ, or Organ Component
T6	PROC 294 314	resonancia magnética
#3	AnnotatorNotes T6	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T7	PROC 336 409	Ensayo clínico fase III unicéntrico, abierto, aleatorizado sobre eficacia
T8	ANAT 443 479	células mononucleadas de médula ósea
T9	DISO 506 532	oclusión coronaria crónica
T10	DISO 535 557	disfunción ventricular
T11	ANAT 546 557	ventricular
#4	AnnotatorNotes T11	C0018827; Heart Ventricle; Body Part, Organ, or Organ Component | C1280934; Entire cardiac ventricle; Body Part, Organ, or Organ Component
T12	PROC 570 586	revascularizados
#5	AnnotatorNotes T12	C0581603; Revascularization - action; Therapeutic or Preventive Procedure
T13	DISO 608 634	Oclusión coronaria crónica
T14	DISO 693 731	enfermedad coronaria arteriosclerótica
T15	DISO 904 926	disfunción ventricular
T16	PROC 981 1001	resonancia magnética
#6	AnnotatorNotes T16	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T17	PROC 1051 1071	fracción de eyección
#7	AnnotatorNotes T17	C0489482; Ejection fraction (procedure); Diagnostic Procedure
T18	PROC 1259 1279	fracción de eyección
#8	AnnotatorNotes T18	C0489482; Ejection fraction (procedure); Diagnostic Procedure
T19	PROC 1334 1348	recanalización
#9	AnnotatorNotes T19	C0034771; Recanalization; Therapeutic or Preventive Procedure
T20	PROC 1354 1363	Serología
#10	AnnotatorNotes T20	C0036743; Serologic tests; Laboratory Procedure
T21	DISO 1420 1443	enfermedades sistémicas
#11	AnnotatorNotes T21	C0442893; Systemic disease; Disease or Syndrome
T22	CHEM 1500 1511	clopidogrel
#12	AnnotatorNotes T22	C0070166; clopidogrel; Organic Chemical · Pharmacologic Substance
T23	CHEM 1514 1522	aspirina
#13	AnnotatorNotes T23	C0004057; aspirin; Organic Chemical · Pharmacologic Substance
T24	DISO 1563 1586	enfermedad hematológica
#14	AnnotatorNotes T24	C0018939; Hematological Disease; Disease or Syndrome
T25	PROC 1678 1699	método anticonceptivo
#15	AnnotatorNotes T25	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T26	PROC 1478 1498	doble antiagregación
T27	PROC 1799 1813	ensayo clínico
#16	AnnotatorNotes T27	C0008976; Clinical Trials; Research Activity
T28	DISO 1866 1882	tumores malignos
#17	AnnotatorNotes T28	C0006826; Malignant Neoplasms; Neoplastic Process
T29	PROC 1949 1969	resonancia magnética
#18	AnnotatorNotes T29	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T30	DISO 1389 1392	VHB
#19	AnnotatorNotes T30	C0019163; Hepatitis B; Disease or Syndrome
T31	PROC 74 97	infusión intracoronaria
T32	ANAT 173 182	coronaria
#20	AnnotatorNotes T32	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T33	PROC 416 439	infusión intracoronaria
T34	ANAT 515 524	coronaria
#21	AnnotatorNotes T34	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T35	ANAT 617 626	coronaria
#22	AnnotatorNotes T35	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T36	ANAT 704 713	coronaria
#23	AnnotatorNotes T36	C0205042; Coronary artery; Body Part, Organ, or Organ Component | C1269008; Entire coronary artery; Body Part, Organ, or Organ Component
T37	DISO 734 753	oclusiones crónicas
T38	PROC 831 861	implantándose stents medicados
#24	AnnotatorNotes T38	C4286029; Drug-eluting stent placement; Therapeutic or Preventive Procedure
T39	ANAT 915 926	ventricular
#25	AnnotatorNotes T39	C0018827; Heart Ventricle; Body Part, Organ, or Organ Component | C1280934; Entire cardiac ventricle; Body Part, Organ, or Organ Component
T40	PROC 1032 1046	recanalización
#26	AnnotatorNotes T40	C0034771; Recanalization; Therapeutic or Preventive Procedure
T41	PROC 1200 1213	recanalizadas
T42	DISO 1177 1196	oclusiones crónicas
T43	DISO 1378 1381	VIH
#27	AnnotatorNotes T43	C0458074; Human immunodeficiency virus (HIV) status; Finding
T44	DISO 1383 1386	VHC
#28	AnnotatorNotes T44	C0019196; Hepatitis C; Disease or Syndrome
T45	Date 13 17	2013
T46	Route 74 82	infusión
#29	AnnotatorNotes T46	C1621368; Intravenous Drip Route of Administration; Functional Concept
T47	LIVB 150 159	pacientes
#30	AnnotatorNotes T47	C0030705; Patients; Patient or Disabled Group
T48	Duration 183 190	crónica
#31	AnnotatorNotes T48	C0205191; chronic; Temporal Concept
T49	DEVI 223 228	stent
#32	AnnotatorNotes T49	C0038257; Stent, device; Medical Device
T50	Route 416 424	infusión
#33	AnnotatorNotes T50	C1621368; Intravenous Drip Route of Administration; Functional Concept
T51	LIVB 492 501	pacientes
#34	AnnotatorNotes T51	C0030705; Patients; Patient or Disabled Group
T52	Duration 525 532	crónica
#35	AnnotatorNotes T52	C0205191; chronic; Temporal Concept
T53	Duration 627 634	crónica
#36	AnnotatorNotes T53	C0205191; chronic; Temporal Concept
T54	LIVB 664 688	Pacientes de ambos sexos
#37	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group + C0025266; Male population group; Population Group + C0043210; Woman; Population Group
T55	Duration 745 753	crónicas
#38	AnnotatorNotes T55	C0205191; chronic; Temporal Concept
T56	Duration 757 771	más de 3 meses
T57	DEVI 845 851	stents
#39	AnnotatorNotes T57	C0038257; Stent, device; Medical Device
T58	Age 950 968	entre 18 y 80 años
T59	Duration 1014 1025	los 3 meses
T60	LIVB 1076 1084	paciente
#40	AnnotatorNotes T60	C0030705; Patients; Patient or Disabled Group
T62	LIVB 1163 1172	Pacientes
#41	AnnotatorNotes T62	C0030705; Patients; Patient or Disabled Group
T63	Duration 1188 1196	crónicas
#42	AnnotatorNotes T63	C0205191; chronic; Temporal Concept
T64	Neg_cue 1197 1199	no
T65	LIVB 1230 1239	Pacientes
#43	AnnotatorNotes T65	C0030705; Patients; Patient or Disabled Group
T67	Duration 1314 1325	los 3 meses
T71	LIVB 1592 1636	Mujeres embarazadas, en periodo de lactancia
#44	AnnotatorNotes T71	C0033011; Pregnant Women; Population Group + C4316174; Patients who are breastfeeding; Patient or Disabled Group
T72	Age 1643 1654	edad fértil
T73	PHYS 1627 1636	lactancia
#45	AnnotatorNotes T73	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T74	Neg_cue 1659 1661	no
T75	LIVB 1712 1721	Pacientes
#46	AnnotatorNotes T75	C0030705; Patients; Patient or Disabled Group
T76	Date 1732 1743	actualmente
T77	Duration 1828 1846	inferior a 3 meses
T78	LIVB 1852 1861	Pacientes
#47	AnnotatorNotes T78	C0030705; Patients; Patient or Disabled Group
T79	LIVB 1903 1912	Pacientes
#48	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	Neg_cue 1924 1926	no
T82	DEVI 2014 2022	prótesis
#49	AnnotatorNotes T82	C0175649; Prosthesis; Medical Device
T83	DEVI 2024 2039	desfibriladores
#50	AnnotatorNotes T83	C0180307; Defibrillators; Medical Device
T84	DEVI 2041 2051	marcapasos
#51	AnnotatorNotes T84	C0030163; Artificial cardiac pacemaker; Medical Device
T85	PHYS 1063 1071	eyección
#52	AnnotatorNotes T85	C2733340; Ventricular ejection; Physiologic Function
T86	PHYS 1271 1279	eyección
#53	AnnotatorNotes T86	C2733340; Ventricular ejection; Physiologic Function
T87	PHYS 1600 1611	embarazadas
#54	AnnotatorNotes T87	C0032961; Pregnancy; Organism Function
T88	PHYS 258 277	función ventricular
#55	AnnotatorNotes T88	C0080309; Ventricular Function; Organ or Tissue Function
A1	Assertion T25 Negated
A2	Assertion T41 Negated
A3	Assertion T29 Negated
A4	Status T49 History_of
A5	Status T4 History_of
A6	Status T12 History_of
A7	Status T2 History_of
A8	Status T38 History_of
A9	Status T57 History_of
A10	Status T40 History_of
A11	Status T41 History_of
A12	Status T19 History_of
A13	Assertion T26 Contraindicated
A14	Assertion T22 Contraindicated
A15	Assertion T23 Contraindicated
A16	Status T27 History_of
#56	AnnotatorNotes T1	C5235893; Bone Marrow-Derived Mononuclear Cells; Cell
#57	AnnotatorNotes T8	C5235893; Bone Marrow-Derived Mononuclear Cells; Cell
#58	AnnotatorNotes T10	C0242973; Ventricular Dysfunction; Pathologic Function 
#59	AnnotatorNotes T15	C0242973; Ventricular Dysfunction; Pathologic Function 
#60	AnnotatorNotes T14	C0010054; Coronary Arteriosclerosis; Disease or Syndrome 
#61	AnnotatorNotes T41	C0034771; Recanalization; Therapeutic or Preventive Procedure
#62	AnnotatorNotes T76	C0521116; Current (present time); Temporal Concept 
R1	Negation Arg1:T64 Arg2:T41	
T61	Quantifier_or_Qualifier 1214 1223	con éxito
A17	Assertion T61 Negated
R2	Has_Quantifier_or_Qualifier Arg1:T41 Arg2:T61	
R3	Negation Arg1:T74 Arg2:T25	
T66	Quantifier_or_Qualifier 1700 1706	eficaz
A18	Assertion T66 Negated
#63	AnnotatorNotes T66	C1704419; Effective; Qualitative Concept
R4	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T66	
R5	Has_Route_or_Mode Arg1:T1 Arg2:T46	
R6	Experiences Arg1:T47 Arg2:T31	
#64	AnnotatorNotes T31	C1553222; Infusion, intracoronary; Functional Concept
#65	AnnotatorNotes T33	C1553222; Infusion, intracoronary; Functional Concept
R7	Experiences Arg1:T47 Arg2:T3	
R8	Location_of Arg1:T32 Arg2:T3	
R9	Has_Duration_or_Interval Arg1:T3 Arg2:T48	
R10	Experiences Arg1:T47 Arg2:T4	
R11	Used_for Arg1:T49 Arg2:T4	
T68	Quantifier_or_Qualifier 138 146	autóloga
#66	AnnotatorNotes T68	C0439859; Autologous (qualifier value); Qualitative Concept
R12	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T68	
R13	Location_of Arg1:T5 Arg2:T88	
R14	Experiences Arg1:T47 Arg2:T88	
R15	Experiences Arg1:T47 Arg2:T6	
R18	Before Arg1:T4 Arg2:T31	
R19	Before Arg1:T31 Arg2:T6	
R20	Has_Route_or_Mode Arg1:T8 Arg2:T50	
R21	Experiences Arg1:T51 Arg2:T33	
T70	Quantifier_or_Qualifier 480 488	autóloga
#68	AnnotatorNotes T70	C0439859; Autologous (qualifier value); Qualitative Concept
R22	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T70	
R23	Experiences Arg1:T51 Arg2:T9	
R24	Location_of Arg1:T34 Arg2:T9	
R25	Has_Duration_or_Interval Arg1:T9 Arg2:T52	
R26	Overlap Arg1:T9 Arg2:T10	
R27	Location_of Arg1:T11 Arg2:T10	
R28	Before Arg1:T12 Arg2:T33	
R29	Experiences Arg1:T51 Arg2:T10	
R30	Experiences Arg1:T51 Arg2:T12	
R31	Location_of Arg1:T35 Arg2:T13	
R32	Has_Duration_or_Interval Arg1:T13 Arg2:T53	
R33	Experiences Arg1:T54 Arg2:T14	
R34	Experiences Arg1:T54 Arg2:T37	
R35	Overlap Arg1:T14 Arg2:T37	
R36	Location_of Arg1:T36 Arg2:T14	
R37	Has_Duration_or_Interval Arg1:T37 Arg2:T56	
R38	Has_Duration_or_Interval Arg1:T37 Arg2:T55	
R39	Experiences Arg1:T54 Arg2:T2	
T81	Quantifier_or_Qualifier 820 829	con éxito
#69	AnnotatorNotes T81	C1272703; Successful; Qualitative Concept
R40	Has_Quantifier_or_Qualifier Arg1:T2 Arg2:T81	
A19	Status T81 History_of
R41	Used_for Arg1:T57 Arg2:T38	
R42	Experiences Arg1:T54 Arg2:T38	
R43	Experiences Arg1:T54 Arg2:T15	
R44	Overlap Arg1:T39 Arg2:T15	
R45	Overlap Arg1:T14 Arg2:T15	
R46	Before Arg1:T2 Arg2:T15	
R47	Before Arg1:T38 Arg2:T15	
R48	Before Arg1:T40 Arg2:T16	
R49	After Arg1:T16 Arg2:T59	
R50	Before Arg1:T40 Arg2:T17	
R52	Experiences Arg1:T60 Arg2:T16	
R53	Experiences Arg1:T60 Arg2:T40	
R54	Experiences Arg1:T60 Arg2:T17	
R55	Experiences Arg1:T60 Arg2:T85	
T89	Result_or_Value 1109 1132	inferior o igual al 45%
R56	Has_Result_or_Value Arg1:T17 Arg2:T89	
R57	Experiences Arg1:T62 Arg2:T42	
R58	Has_Duration_or_Interval Arg1:T42 Arg2:T63	
R59	Experiences Arg1:T62 Arg2:T41	
#70	AnnotatorNotes T61	C1272703; Successful; Qualitative Concept
R60	Negation Arg1:T64 Arg2:T61	
R61	Experiences Arg1:T65 Arg2:T18	
R62	Experiences Arg1:T65 Arg2:T86	
T90	Observation 1244 1252	mejorías
R64	Experiences Arg1:T65 Arg2:T90	
#71	AnnotatorNotes T90	C0184511; Improved; Finding (?)
T91	Result_or_Value 1294 1311	superiores al 45%
R65	Has_Result_or_Value Arg1:T18 Arg2:T91	
R66	After Arg1:T90 Arg2:T67	
R67	After Arg1:T90 Arg2:T19	
R68	After Arg1:T18 Arg2:T67	
R69	After Arg1:T18 Arg2:T19	
R70	Experiences Arg1:T65 Arg2:T19	
T92	Result_or_Value 1364 1372	positiva
#72	AnnotatorNotes T92	C1446409; Positive; Finding
R71	Has_Result_or_Value Arg1:T20 Arg2:T92	
R75	Causes Arg1:T43 Arg2:T92	
R76	Causes Arg1:T44 Arg2:T92	
R77	Causes Arg1:T30 Arg2:T92	
T93	Quantifier_or_Qualifier 1444 1450	graves
#73	AnnotatorNotes T93	C1547227; Severe - Severity of Illness Code; Intellectual Product
R78	Has_Quantifier_or_Qualifier Arg1:T21 Arg2:T93	
R80	Used_for Arg1:T22 Arg2:T26	
R81	Combined_with Arg1:T22 Arg2:T23	
#75	AnnotatorNotes T26	C5197905; Dual Anti-Platelet Therapy; Therapeutic or Preventive Procedure
R82	Experiences Arg1:T71 Arg2:T87	
R83	Experiences Arg1:T71 Arg2:T73	
R84	Has_Age Arg1:T71 Arg2:T72	
R86	Negation Arg1:T74 Arg2:T66	
R85	Overlap Arg1:T27 Arg2:T77	
T95	Observation 1744 1756	participando
#76	AnnotatorNotes T95	C1278516; Patient participation status; Finding
R87	Overlap Arg1:T95 Arg2:T76	
T96	Observation 1765 1792	finalizado su participación
#77	AnnotatorNotes T96	C2732579; Completion of clinical trial; Finding
A21	Status T96 History_of
R88	Experiences Arg1:T78 Arg2:T28	
T97	Quantifier_or_Qualifier 1885 1897	pre-malignos
#78	AnnotatorNotes T97	C1514391; Premalignant; Qualitative Concept
R89	Experiences Arg1:T79 Arg2:T29	
R90	Negation Arg1:T80 Arg2:T29	
R91	Overlap Arg1:T29 Arg2:T82	
R92	Overlap Arg1:T29 Arg2:T83	
R93	Overlap Arg1:T29 Arg2:T84	
R94	Experiences Arg1:T79 Arg2:T82	
R95	Experiences Arg1:T79 Arg2:T83	
R96	Experiences Arg1:T79 Arg2:T84	
R98	Combined_with Arg1:T2 Arg2:T38	
R99	Overlap Arg1:T96 Arg2:T77	
T69	Observation 244 251	mejoría
#67	AnnotatorNotes T69	C0184511; Improved; Finding (?)
A20	Experiencer T47 Patient
A22	Experiencer T51 Patient
A23	Experiencer T54 Patient
A24	Experiencer T60 Patient
A25	Experiencer T62 Patient
A26	Experiencer T65 Patient
A27	Experiencer T71 Patient
A28	Experiencer T75 Patient
A29	Experiencer T78 Patient
A30	Experiencer T79 Patient
